drugset / Trial / NCT04342273
A Through QT/QTc Study of KW-6356
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effects of multiple therapeutic and supratherapeutic doses of KW-6356 on the QT interval corrected for heart rate in Japanese healthy adults.
Timeline
- Start
- 2020-03-31
- Primary completion
- 2020-09-05
- Completion
- 2020-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | — | Oral |
| Subject | SIPAGLADENANT | Small molecule | — | Oral |